Monkeys respond well to Ebola vaccine in study

05/24/2010 | HealthDay News

A vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases appeared to protect cynomolgus macaque monkeys from three strains of the Ebola virus. "This finding will guide future vaccine design and may open an avenue for developing a single vaccine that works against both known and emerging Ebola virus species," said Anthony Fauci, director of the institute.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC